Advanced neuroimaging in stroke patients: prediction of tissue fate and hemorrhagic transformation

References

• Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke24(1), 35–41 (1993).
   PubMed Web of Science ®Google Scholar
• Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol.6(3), 258–268 (2007).
   PubMed Web of Science ®Google Scholar
• Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet355(9216), 1670–1674 (2000).
   PubMed Web of Science ®Google Scholar
• Merino JG, Warach S. Imaging of acute stroke. Nat. Rev. Neurol.6(10), 560–571 (2010).
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment – systematic review. Radiology235(2), 444–453 (2005).
   PubMed Web of Science ®Google Scholar
• Chalela JA, Kidwell CS, Nentwich LM et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet369(9558), 293–298 (2007).
   PubMed Web of Science ®Google Scholar
• Schellinger PD, Bryan RN, Caplan LR et al. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology75(2), 177–185 (2010).
   PubMed Web of Science ®Google Scholar
• Hjort N, Christensen S, Solling C et al. Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann. Neurol.58(3), 462–465 (2005).
   PubMedGoogle Scholar
• Inatomi Y, Kimura K, Yonehara T, Fujioka S, Uchino M. DWI abnormalities and clinical characteristics in TIA patients. Neurology62(3), 376–380 (2004).
   PubMedGoogle Scholar
• Forster A, Gass A, Kern R et al. Brain imaging in patients with transient ischemic attack: a comparison of computed tomography and magnetic resonance imaging. Eur. Neurol.67(3), 136–141 (2012).
   PubMedGoogle Scholar
• Baird AE, Benfield A, Schlaug G et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann. Neurol.41(5), 581–589 (1997).
   PubMed Web of Science ®Google Scholar
• Schwamm LH, Koroshetz WJ, Sorensen AG et al. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke29(11), 2268–2276 (1998).
   PubMed Web of Science ®Google Scholar
• Lansberg MG, O’Brien MW, Tong DC, Moseley ME, Albers GW. Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch. Neurol.58(4), 613–617 (2001).
   PubMedGoogle Scholar
• Campbell BC, Purushotham A, Christensen S et al. The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J. Cereb. Blood Flow Metab.32(1), 50–56 (2012).
   PubMed Web of Science ®Google Scholar
• Ozsunar Y, Sorensen AG. Diffusion- and perfusion-weighted magnetic resonance imaging in human acute ischemic stroke: technical considerations. Top. Magn. Reson. Imaging11(5), 259–272 (2000).
   PubMedGoogle Scholar
• Sanak D, Nosal V, Horak D et al. Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis. Neuroradiology48(9), 632–639 (2006).
   PubMedGoogle Scholar
• Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, Gonzalez RG. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke40(6), 2046–2054 (2009).
   PubMedGoogle Scholar
• Kang DW, Chalela JA, Ezzeddine MA, Warach S. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Arch. Neurol.60(12), 1730–1734 (2003).
   PubMedGoogle Scholar
• Fiebach JB, Schellinger PD, Gass A et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke35(2), 502–506 (2004).
   PubMed Web of Science ®Google Scholar
• Thijs V, Lemmens R, Schoofs C et al. Microbleeds and the risk of recurrent stroke. Stroke41(9), 2005–2009 (2010).
   PubMedGoogle Scholar
• Bokura H, Saika R, Yamaguchi T et al. Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals. Stroke42(7), 1867–1871 (2011).
   PubMed Web of Science ®Google Scholar
• Boulanger JM, Coutts SB, Eliasziw M et al. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke37(3), 911–914 (2006).
   PubMed Web of Science ®Google Scholar
• Latchaw RE, Alberts MJ, Lev MH et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke40(11), 3646–3678 (2009).
   PubMed Web of Science ®Google Scholar
• Thomalla G, Rossbach P, Rosenkranz M et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann. Neurol.65(6), 724–732 (2009).
   PubMed Web of Science ®Google Scholar
• Campbell BC, Costello C, Christensen S et al. Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation. Cerebrovasc. Dis.32(4), 401–405 (2011).
   PubMedGoogle Scholar
• Leys D, Pruvo JP, Godefroy O, Rondepierre P, Leclerc X. Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke23(3), 317–324 (1992).
   PubMed Web of Science ®Google Scholar
• Kim EY, Lee SK, Kim DJ et al. Detection of thrombus in acute ischemic stroke: value of thin-section noncontrast-computed tomography. Stroke36(12), 2745–2747 (2005).
   PubMed Web of Science ®Google Scholar
• Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke42(6), 1775–1777 (2011).
   PubMed Web of Science ®Google Scholar
• Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am. J. Neuroradiol.26(3), 618–624 (2005).
   PubMed Web of Science ®Google Scholar
• Lee KY, Latour LL, Luby M, Hsia AW, Merino JG, Warach S. Distal hyperintense vessels on FLAIR: an MRI marker for collateral circulation in acute stroke? Neurology72(13), 1134–1139 (2009).
   PubMed Web of Science ®Google Scholar
• Bash S, Villablanca JP, Jahan R et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am. J. Neuroradiol.26(5), 1012–1021 (2005).
   PubMed Web of Science ®Google Scholar
• Tan JC, Dillon WP, Liu S, Adler F, Smith WS, Wintermark M. Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann. Neurol.61(6), 533–543 (2007).
   PubMed Web of Science ®Google Scholar
• Lev MH, Farkas J, Rodriguez VR et al. CT angiography in the rapid triage of patients with hyperacute stroke to intra-arterial thrombolysis: accuracy in the detection of large vessel thrombus. J. Comput. Assist. Tomogr.25(4), 520–528 (2001).
   PubMed Web of Science ®Google Scholar
• Miteff F, Levi CR, Bateman GA, Spratt N, Mcelduff P, Parsons MW. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain132(Pt 8), 2231–2238 (2009).
   PubMedGoogle Scholar
• Mcverry F, Liebeskind DS, Muir KW. Systematic review of methods for assessing leptomeningeal collateral flow. AJNR Am. J. Neuroradiol. doi:10.3174/ajnr.A2794 (2012) (Epub ahead of print).
   PubMedGoogle Scholar
• Debrey SM, Yu H, Lynch JK et al. Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: a systematic review and meta-analysis. Stroke39(8), 2237–2248 (2008).
   PubMedGoogle Scholar
• Alfke K, Jensen U, Pool C et al. Contrast-enhanced magnetic resonance angiography in stroke diagnostics: additional information compared with time-of-flight magnetic resonance angiography? Clin. Neuroradiol.21(1), 5–10 (2011).
   PubMedGoogle Scholar
• Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N. Engl. J. Med.344(12), 898–906 (2001).
   PubMed Web of Science ®Google Scholar
• Dani KA, Thomas RG, Chappell FM et al. Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds. Ann. Neurol.70(3), 384–401 (2011).
   PubMedGoogle Scholar
• Pollock JM, Tan H, Kraft RA, Whitlow CT, Burdette JH, Maldjian JA. Arterial spin-labeled MR perfusion imaging: clinical applications. Magn. Reson. Imaging Clin. N. Am.17(2), 315–338 (2009).
   PubMedGoogle Scholar
• Grandin CB. Assessment of brain perfusion with MRI: methodology and application to acute stroke. Neuroradiology45(11), 755–766 (2003).
   PubMedGoogle Scholar
• Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn. Reson. Med.14(2), 249–265 (1990).
   PubMed Web of Science ®Google Scholar
• Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: comparison of methodologies. Magn. Reson. Med.43(4), 559–564 (2000).
   PubMedGoogle Scholar
• Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn. Reson. Med.46(6), 1113–1122 (2001).
   PubMedGoogle Scholar
• Knutsson L, Stahlberg F, Wirestam R. Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities. MAGMA23(1), 1–21 (2010).
   PubMedGoogle Scholar
• Kane I, Carpenter T, Chappell F et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke38(12), 3158–3164 (2007).
   PubMedGoogle Scholar
• Christensen S, Mouridsen K, Wu O et al. Comparison of 10 perfusion MRI parameters in 97 sub-6-hour stroke patients using voxel-based receiver operating characteristics analysis. Stroke40(6), 2055–2061 (2009).
   PubMedGoogle Scholar
• Schlaug G, Benfield A, Baird AE et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology53(7), 1528–1537 (1999).
   PubMed Web of Science ®Google Scholar
• Jansen O, Schellinger P, Fiebach J, Hacke W, Sartor K. Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet353(9169), 2036–2037 (1999).
   PubMed Web of Science ®Google Scholar
• Albers GW, Thijs VN, Wechsler L et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann. Neurol.60(5), 508–517 (2006).
   PubMed Web of Science ®Google Scholar
• Furlan AJ, Eyding D, Albers Gw et al. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke37(5), 1227–1231 (2006).
   PubMed Web of Science ®Google Scholar
• Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke trial (DIAS): a Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke36(1), 66–73 (2005).
   PubMed Web of Science ®Google Scholar
• Hacke W, Furlan AJ, Al-Rawi Y et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol.8(2), 141–150 (2009).
   PubMed Web of Science ®Google Scholar
• Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol.7(4), 299–309 (2008).
   PubMed Web of Science ®Google Scholar
• Nagakane Y, Christensen S, Brekenfeld C et al. EPITHET: positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-Registration. Stroke42(1), 59–64 (2011).
   PubMedGoogle Scholar
• Lansberg MG, Lee J, Christensen S et al. RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Stroke42(6), 1608–1614 (2011).
   PubMed Web of Science ®Google Scholar
• Berger C, Fiorelli M, Steiner T et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke32(6), 1330–1335 (2001).
   PubMed Web of Science ®Google Scholar
• Saver JL. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke38(8), 2279–2283 (2007).
   PubMed Web of Science ®Google Scholar
• Gumbinger C, Gruschka P, Bottinger M et al. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage. Stroke43(1), 240–242 (2012).
   PubMedGoogle Scholar
• Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet352(9136), 1245–1251 (1998).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med.359(13), 1317–1329 (2008).
   PubMed Web of Science ®Google Scholar
• No authors listed. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med.333(24), 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA282(21), 2019–2026 (1999).
   PubMed Web of Science ®Google Scholar
• Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ172(10), 1307–1312 (2005).
   PubMed Web of Science ®Google Scholar
• Shobha N, Buchan AM, Hill MD. Thrombolysis at 3–4.5 hours after acute ischemic stroke onset – evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Cerebrovasc. Dis.31(3), 223–228 (2011).
   PubMed Web of Science ®Google Scholar
• Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA282(21), 2003–2011 (1999).
   PubMed Web of Science ®Google Scholar
• Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke36(7), 1432–1438 (2005).
   PubMed Web of Science ®Google Scholar
• Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke39(4), 1205–1212 (2008).
   PubMed Web of Science ®Google Scholar
• IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke38(7), 2127–2135 (2007).
   PubMed Web of Science ®Google Scholar
• Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol. Neurobiol.28(3), 229–244 (2003).
   PubMed Web of Science ®Google Scholar
• Kim EY, Na DG, Kim SS, Lee KH, Ryoo JW, Kim HK. Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement. AJNR Am. J. Neuroradiol.26(5), 1050–1055 (2005).
   PubMedGoogle Scholar
• Merten CL, Knitelius HO, Assheuer J, Bergmann-Kurz B, Hedde JP, Bewermeyer H. MRI of acute cerebral infarcts, increased contrast enhancement with continuous infusion of gadolinium. Neuroradiology41(4), 242–248 (1999).
   PubMedGoogle Scholar
• Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood–brain barrier disruption in human focal brain ischemia. Ann. Neurol.56(4), 468–477 (2004).
   PubMed Web of Science ®Google Scholar
• Vo KD, Santiago F, Lin W, Hsu CY, Lee Y, Lee JM. MR imaging enhancement patterns as predictors of hemorrhagic transformation in acute ischemic stroke. AJNR Am. J. Neuroradiol.24(4), 674–679 (2003).
   PubMed Web of Science ®Google Scholar
• Kastrup A, Groschel K, Ringer TM et al. Early disruption of the blood–brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke39(8), 2385–2387 (2008).
   PubMedGoogle Scholar
• Hom J, Dankbaar JW, Schneider T, Cheng SC, Bredno J, Wintermark M. Optimal duration of acquisition for dynamic perfusion CT assessment of blood–brain barrier permeability using the Patlak model. AJNR Am. J. Neuroradiol.30(7), 1366–1370 (2009).
   PubMedGoogle Scholar
• Aviv RI, D’Esterre CD, Murphy BD et al. Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology250(3), 867–877 (2009).
   PubMed Web of Science ®Google Scholar
• Hom J, Dankbaar JW, Soares BP et al. Blood–brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am. J. Neuroradiol.32(1), 41–48 (2011).
   PubMedGoogle Scholar
• Kassner A, Roberts T, Taylor K, Silver F, Mikulis D. Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. AJNR Am. J. Neuroradiol.26(9), 2213–2217 (2005).
   PubMedGoogle Scholar
• Vidarsson L, Thornhill RE, Liu F, Mikulis DJ, Kassner A. Quantitative permeability magnetic resonance imaging in acute ischemic stroke: how long do we need to scan? Magn. Reson. Imaging27(9), 1216–1222 (2009).
   PubMedGoogle Scholar
• Bang OY, Buck BH, Saver JL et al. Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann. Neurol.62(2), 170–176 (2007).
   PubMedGoogle Scholar
• Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke41(5), 932–937 (2010).
   PubMed Web of Science ®Google Scholar
• Mazighi M, Serfaty JM, Labreuche J et al. Comparison of intravenous alteplase with a combined intravenous–endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol.8(9), 802–809 (2009).
   PubMed Web of Science ®Google Scholar
• Soares BP, Tong E, Hom J et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke41(1), e34–e40 (2010).
   PubMed Web of Science ®Google Scholar
• Bang OY, Saver JL, Buck BH et al. Impact of collateral flow on tissue fate in acute ischaemic stroke. J. Neurol. Neurosurg. Psychiatry79(6), 625–629 (2008).
   PubMed Web of Science ®Google Scholar
• Campbell BC, Christensen S, Butcher KS et al. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke41(1), 82–88 (2010).
   PubMed Web of Science ®Google Scholar
• von Kummer R, Bourquain H, Bastianello S et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology219(1), 95–100 (2001).
   PubMed Web of Science ®Google Scholar